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Efficacy of Repeated Choral Reading for Individuals with Chronic Nonfluent Aphasia 
 
Oral Reading for Language in Aphasia (ORLA) is a treatment technique in which the 
person with aphasia repeatedly reads aloud sentences and paragraphs, first in unison with the 
clinician, and then independently.  Based on neuropsychological models of reading, ORLA was 
developed to improve reading comprehension in individuals with aphasia by providing practice 
in the phonological and semantic reading routes.   
 
However, in preliminary studies, improvements in other modalities, including oral 
expression, auditory comprehension, and written expression were seen in both fluent and 
nonfluent aphasia (Cherney, 1996; 2004; Cherney et al., 1986, 1995, 2004). Several explanations 
for the cross-modal generalization have been suggested, and these may be related to other 
features of the ORLA technique.  For example, ORLA focuses on connected discourse rather 
than single words, permitting the modeling of more natural rhythm and intonations. It also allows 
practice on a variety of grammatical structures, rather than just one specific grammatical form. 
ORLA is consistent with a stimulation approach (Schuell et al., 1964; Duffy & Coelho, 2001), 
using repetitive multimodality stimulation to elicit a response.  It is also consistent with 
principles of learning theory, such as active participation by the learner, repetitive practice in the 
overlearning of skills, and use of meaningful materials that are graded in difficulty.  ORLA has 
four levels based on length and reading level: Level 1. Simple 3-5 word sentences at a first grade 
reading level; Level 2. 8-12 words that may be single sentences or two short sentences, at a third 
grade reading level; Level 3. 15-30 words, divided into 2-3 sentences, at a sixth grade reading 
level;  Level 4. 50-100 words comprising a 4-6 sentence simple paragraph, also at a sixth grade 
reading level.  The graded nature of ORLA therefore makes it appropriate for individuals who 
present with a broad range of aphasia severities.   
 
This presentation reports the results of ORLA, administered to 25 individuals with 
chronic nonfluent aphasia of varying severity levels.  The possibility that generalization to 
specific modalities may be related to severity of aphasia is explored. 
 
 
METHODS 
 
Subjects 
25 individuals (16 males; 9 females) with chronic aphasia (more than 12 months post 
onset ) participated. All subjects were right handed, with at least a 12th grade education. Age at 
time of stroke onset ranged from 25.2 years to 80.36 years, and age at time of initial testing 
ranged from 35.18 years to 81.65 years.  All subjects were classified with nonfluent aphasia, and 
none were considered clinically to present with global aphasia.  However, severity of the 
aphasia, as determined by the Aphasia Quotient (AQ) of the Western Aphasia Battery varied 
greatly.  Therefore, subjects were divided into three groups based on severity.  AQ range for 6 
severe subjects was 9.7 – 21.1 (mean = 13.73; SD =3.97); AQ  range for 9 subjects in the 
moderate group was 49.4 – 60.7 (mean = 54.74; SD = 3.53); and AQ range for 10 subjects with 
mild-moderate aphasia was 66 – 81.5 (mean = 76.84; SD = 5.56). 
 
A delayed treatment design was utilized; therefore all subjects received treatment 
following a period of no-treatment.  Subjects were initially evaluated (Baseline testing) using the 
Western Aphasia Battery (WAB), four subtests of the Reading Comprehension Battery for 
Aphasia (RCBA-2), and several discourse measures. RCBA-2 subtests included paragraph level 
reading (Paragraph-Picture, Paragraph-Factual, Paragraph-Inferential) as well as Functional 
Reading,  Discourse tasks included descriptions of two composite pictures and two narratives 
based on a series of picture sequences (Nicholas & Brookshire, 1993).  The elicited discourse 
samples were analyzed for rate of speech (words per minute) and informational content (CIU’s 
per minutes).  A second  assessment (Pre-treatment testing) occurred 7-12 weeks later, following 
a no-treatment period.  Subjects then participated in 24 one-hour sessions of ORLA treatment, 
typically twice a week.  A post-treatment assessment took place immediately after the end of 
treatment.  A comparison of change in scores from baseline to pre-treatment versus pre-treatment 
to post-treatment provides an index of the efficacy of the ORLA treatment. 
 
RESULTS 
 
Preliminary statistical analyses for the group as a whole indicated a mean change in AQ 
test scores from pre- to post-treatment of  3.4 (SD = 4.5) compared to a mean change of  -0.36 
(SD = 3.1) in the 8-12 week pre-treatment interval.  
 
Since we are interested in how ORLA impacts aphasic individuals of different severity 
levels, Table 1 presents results for each of the three severity levels.  Because of the relatively 
small numbers of subjects per severity group, statistical analyses have not been conducted – 
rather trends are discussed in relation to each severity group.    
 
For subjects with severe aphasia, the most noticeable change from pre-treatment to post-
treatment was in the WAB Reading scores.  Since ORLA was initially designed to improve 
reading comprehension, this finding is not surprising.  A small but noticeable change in reading 
scores from pre- to post-treatment was also obtained on selected subtests of the RCBA-2.  With 
regard to discourse production, increased rate of speech (words / minute) was found on the 
picture description task, but responses across subjects were variable. 
 
For subjects with moderate aphasia, mean change on the WAB AQ was greater from pre-
treatment to post-treatment as compared to baseline to pre-treatment.  However, the mean WAB 
AQ change from pre- to post-treatment was relatively small, and it is difficult to ascertain the 
functional significance of this mean change.  Examination of individual scores showed that one 
subject obtained a WAB AQ increase of 16.3 points as compared to pre-treatment and 12.2 
points as compared to baseline; two other subjects showed gains of 9.3 points and 4.9 points 
respectively.  Reading comprehension improved on the RCBA-2, but this change was not seen in 
the WAB reading scores.  A greater increase in CIU’s per minute, particularly for the narrative 
discourse, was evident from pre- to post-treatment.  
 
For subjects with  mild-moderate aphasia, mean change on the WAB AQ was greater 
from pre-treatment to post-treatment as compared to baseline to pre-treatment, with 4 of the 
subjects demonstrating a change of greater than 6 points.  The greatest  pre-post treatment 
change was on the WAB writing and on the discourse measures, with increases noted for both 
words/minute and CIU’s/minute for picture description and narrative discourse tasks. 
 
DISCUSSION AND CLINICAL IMPLICATIONS 
 
Results indicate that subjects with severe aphasia displayed greatest improvements in 
reading, while subjects with mild-moderate aphasia displayed changes in writing and in 
discourse production.   These results will be discussed in relation to both group data, as well as in 
relation to data obtained on individual subject performance.   Interpretation of results will also 
consider the sensitivity of the tests that were used as outcome measures and clinical implications 
for use of these tests.  It is also of interest to note that the severe group was also the oldest group; 
in addition to the impact of age on outcome, other demographic variables that may affect results 
will be explored.   
 
Clinical implications regarding intensity of the ORLA treatment also will be addressed.  
In this study, although the number of treatment sessions was consistent across subjects, the 
frequency of treatment was low.   Greater changes may be anticipated if treatment is 
administered at a higher frequency and this will be discussed in the light of recent research that 
suggests the need for high frequency of treatment for individuals with aphasia. 
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Table 1.  Demographic Information and Test Scores  
 
 Severe Aphasia 
(AQ < 25) 
Moderate Aphasia 
(AQ 45-65) 
Mild-Moderate 
aphasia  (AQ 66-85)
Number of subjects 6 9 10 
Males : Females 2 : 4 5 : 4 9 : 1 
Age at stroke onset 
   Mean (Std Dev.) 
   Range 
 
66.33 (11.79) 
50.21 – 80.36 
 
51.62  (17.59) 
25.20 – 78.60 
 
50.59 (9.10) 
33.95 – 64.03 
Months post onset 
   Mean (Std Dev) 
   Range 
 
31.98 (24.13) 
12.36 – 71.97 
 
71.83 (83.86) 
12.16 – 253.21 
 
47.34 (43.38) 
12.16 – 138.56 
Age at Baseline testing 
   Mean (Std Dev.) 
   Range 
 
69.00 (10.28) 
56.22 – 81.65 
 
57.61 (13.46) 
39.06 – 79.64 
 
54.54 (10.74) 
35.18 – 71.95 
WAB AQ –        
   Baseline 
   Pretreatment 
   Post-treatment 
 
13.73 (3.97) 
15.73 (4.78) 
18.48 (5.06) 
 
54.74 (3.53) 
54.91 (6.75) 
57.34 (5.93) 
 
76.84 (5.56) 
77.63 (6.36) 
79.75 (4.71) 
WAB Reading –   
   Baseline 
   Pretreatment 
   Post-treatment 
 
29.00 (13.94) 
26.83 (14.29) 
33.83 (14.03) 
 
61.56 (17.11) 
65.89 (15.49) 
58.44 (15.93) 
 
85.90 (9.61) 
88.40 (9.41) 
87.80 (9.34) 
WAB Writing –  
   Baseline 
   Pretreatment 
   Post-treatment 
 
8.17 (6.14) 
7.42 (6.61) 
7.33 (6.06) 
 
38.50 (16.65) 
41.22 (17.65) 
39.78 (20.22) 
 
69.60 (15.99) 
69.35 (17.08) 
75.05 (18.66) 
RCBA – 4 subtests 
   Baseline 
   Pre-treatment 
   Post-treatment 
 
6.17 (4.75) 
6.50 (4.0) 
7.50 (6.16) 
 
17.44 (8.60) 
17.78 (10.72) 
20.22 (10.84) 
 
32.10 (4.12) 
31.60 (33) 
32.00 (6.63) 
Discourse Wds/min 
Picture description 
   Baseline 
   Pre-treatment 
   Post-treatment 
 
 
9.58 (7.50) 
7.90 (9.47) 
12.19 (22.69) 
 
 
34.15 (21.36) 
32.93 (21.36) 
33.31 (17.48) 
 
 
44.85 (19.90) 
44.70 (20.89) 
55.65 (18.51) 
Discourse CIUs/min 
Picture description 
   Baseline 
   Pre-treatment 
   Post-treatment 
 
 
0.00 (0.00) 
0.00 (0.00) 
0.00 (0.00) 
 
 
10.96 (10.10) 
11.55 (8.99) 
12.17 (9.13) 
 
 
26.49 (16.52) 
26.11 (13.81) 
31.93 (13.49) 
Discourse Wds/min 
Narrative 
   Baseline 
   Pre-treatment 
   Post-treatment 
 
 
5.37 (4.39) 
10.12 (11.17) 
11.89 (18.78) 
 
 
39.44 (19.07) 
31.89 (23.27) 
35.75 (16.91) 
 
 
45.82 (17.74) 
47.76 (23.64) 
55.90 (20.96) 
Discourse CIUs/min 
Narrative 
   Baseline 
   Pre-treatment 
   Post-treatment 
 
 
0.00 (0.00) 
0.11 (0.27) 
0.19 (0.46) 
 
 
10.90 (9.84) 
10.39 (10.32) 
15.18 (12.88) 
 
 
24.54 (12.67) 
28.73 (15.37) 
31.28 (14.52) 
 
